Effects of tailored exercise on glycemic and nutritional outcomes in diabetic patients with colorectal cancer and on chemotherapy

Table 3 Comparison of baseline colorectal cancer characteristics between two groups, n (%)

Parameters	SC group (n = 111)	IET group (n = 134)	t/χ²	P value
Tumor site			0.2	0.654
Segmented colon	69 (62.16)	87 (64.93)
Rectum	42 (37.84)	47 (35.07)
Tumor size at diagnosis			1.108	0.575
< 4 cm	41 (36.94)	41 (30.6)
4-6 cm	36 (32.43)	47 (35.07)
> 6 cm	34 (30.63)	46 (34.33)
TNM staging			0.313	0.855
Stage I	25 (22.52)	31 (23.13)
Stage II	45 (40.54)	58 (43.28)
Stage III	41 (36.94)	45 (33.58)
Disease duration			1.222	0.543
< 3 months	36 (32.43)	47 (35.07)
3-6 months	38 (34.23)	51 (38.06)
> 6 months	37 (33.33)	36 (26.87)
Surgical method			0.17	0.68
Palliative surgery	76 (68.47)	95 (70.9)
Radical surgery	35 (31.53)	39 (29.1)
ECOG			0.158	0.924
Grade 0	21 (18.92)	26 (19.4)
Grade 1	22 (19.82)	29 (21.64)
Grade 2	68 (61.26)	79 (58.96)

IET: Individualized exercise training; SC: Standard care; TNM: Tumor node metastasis classification; ECOG: Eastern Cooperative Oncology Group.